CTN-0067 CRF CSV Data
CTN-0093 CRF CSV Data
CTN-0093 CRF SAS Data
Tobacco, Alcohol, Prescription Medication, and Other Substance Use Screening
The TAPS Tool, developed by a study team in the NIDA Clinical Trials Network (CTN-0059), is a 2-step screening and brief assessment approach. TAPS-1, the screening component, asks about frequency of use of tobacco, alcohol (above guideline-recommended daily limits), illicit drugs, and nonmedical use of prescription medications within the previous 12 months. If the participants reports having used one of the substances, TAPS-2 then asks more specific follow-up questions regarding use in the past 3 months
Prescription Opioid Misuse Index
This 6-item interview is focused specifically on prescription opioid use behaviors. It was developed and used in a larger study designed to assess correlates of OxyContin abuse in pain patients prescribed OxyContin, patients treated for OxyContin addiction, and individuals incarcerated for OxyContin-related charges. The original 8-item POMI included questions regarding dose, frequency of use, the need for early refills, a doctor expressing concern of misuse, feeling high from the medication, taking medication due to stress, obtaining prescriptions from multiple physicians, and pain control. It also included a question regarding adequate pain relief to confirm that any increase in prescription use reported was not due to inadequate pain control.